Monica Dinescu

Monica Dinescu serves as an Assistant Researcher at the National Institute of Materials Physics in Magurele, Romania, where she has been conducting research since 2013. She is simultaneously pursuing her PhD at University POLITEHNICA of Bucharest in the Faculty of Applied Chemistry and Materials Science. Her research focuses on the photodegradation mechanisms of pharmaceutical compounds using advanced spectroscopic techniques including UV-vis, FTIR absorption, Raman, and Photoluminescence.

Her educational background includes a Master's degree in Micro and Nano-materials from University POLITEHNICA of Bucharest (2013-2015) and a Graduate degree in Chemical Engineering from the same institution (2009-2013), with specialization in Science and Engineering of Oxide Materials and Nano-materials.

Dinescu's research interests center on the interaction between nanomaterials and pharmaceutical compounds, with particular emphasis on photodegradation processes. She investigates how materials like graphene oxide, carbon nanotubes, and TiO2 nanoparticles affect the stability of drugs including acetaminophen, nifedipine, ampicillin, and melatonin. Her work combines materials synthesis with advanced spectroscopic characterization to develop new analytical methods for pharmaceutical quality control.

Analysis of her publication record reveals a strong focus on applying photoluminescence as a complementary tool to traditional UV-VIS spectroscopy for monitoring drug photodegradation. Her research demonstrates how different nanomaterials can either enhance or inhibit photodegradation processes, with implications for pharmaceutical formulation and storage.

Dinescu has contributed to two patents related to pharmaceutical formulations and sensor development, demonstrating the practical applications of her research. Her work on azathioprine polymorphs and graphene-based sensors for epidermal growth factor receptor detection shows translational potential for drug development and medical diagnostics.

She has collaborated extensively with Mihaela Baibarac and other researchers at the National Institute of Materials Physics, contributing to numerous publications that bridge materials science and pharmaceutical chemistry. Her expertise in spectroscopic characterization of drug-nanomaterial interactions positions her at the forefront of pharmaceutical nanotechnology research.